Cost and effectiveness of brinzolamide versus dorzolamide in current practice: an analysis based on the UK-GPRD database
- 1 January 2003
- journal article
- Published by Informa Healthcare in Journal of Medical Economics
- Vol. 6 (1-4) , 69-78
- https://doi.org/10.3111/200306069078
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Cost-Minimisation Study of Dorzolamide versus Brinzolamide in the Treatment of Ocular Hypertension and Primary Open-Angle GlaucomaPharmacoEconomics, 2003
- Comparisons of Intraocular-Pressure- Lowering Efficacy and Side Effects of 2% Dorzolamide and 1% BrinzolamideOphthalmologica, 2001
- Patients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice settingClinical Therapeutics, 2000
- Number of people with glaucoma worldwide.British Journal of Ophthalmology, 1996
- The Economic Burden of Glaucoma in the UKPharmacoEconomics, 1995
- The management of elevated intraocular pressure with normal optic discs and visual fieldsSurvey of Ophthalmology, 1977